Figure 1
Relapse and non-relapse mortality after alloHSCT according to molecular subgroups. Cumulative incidence plots illustrating the combined influence of NMP1 and FLT3 mutational status on (A) relapse (CIR) and (B) non-relapse mortality (NRM).
Relapse and non-relapse mortality after alloHSCT according to molecular subgroups. Cumulative incidence plots illustrating the combined influence of NMP1 and FLT3 mutational status on (A) relapse (CIR) and (B) non-relapse mortality (NRM).
